Skip to main content

Proceeding contribution from Lord Patel (Crossbench) in the House of Lords on Monday, 28 November 2011. It occurred during Debate on bill and Committee of the Whole House (HL) on Health and Social Care Bill.


Health and Social Care Bill

My Lords, I support the amendments tabled by the noble Lord, Lord Warner, to which I have added my name. First, I will speak very briefly about innovation and procurement. I also contributed to the report by the Science and Technology Committee on procurement. The public sector could learn a lot from the private sector about using procurement to drive innovation. Perhaps the Minister can comment on this. The NHS is a huge organisation that uses about £20 billion-worth of procurement a year and if that was done in a co-ordinated way, it could drive an immense amount of innovation within the NHS. My second point is about how to drive innovation into clinical care. There are lots of examples I could give, but I will give one from my own specialty. It took us 20 years to take the learning from research into the kind of treatment to be given to the mother in premature labour that would considerably reduce the incidence of respiratory distress syndrome, which causes a lot of harm and death in neonates, and embed that into practice. There are lots of examples of such innovations not being embedded into the NHS and we need to look at ways of doing that faster. My third point is how to use tariffs to drive innovation. If I as a provider will not be given a higher tariff if I drive innovation or innovate a different way of providing the service, and all that will happen is that the tariff for procuring my services as a provider will be less the following year, there is less incentive for me to use innovation in clinical care to improve patient care and also to make it cheaper. The fourth issue is about an innovation fund, which I support. Together with the Wellcome Trust, the Government have an innovation challenge fund that asks for tenders in particular areas of innovation. The one I know about is in reducing infection rates. Innovation funds of this kind will drive further innovation; for example, in the United States Medicaid and Medicare have a joint innovation fund to drive improvements in healthcare. So I support that amendment.


Secondary information

Type
Proceeding contribution
Reference
733 c72 
Session
2010-12
Chamber / Committee
House of Lords chamber
Subjects
Disclosure of information Health Health services Innovation Private sector Higher education NHS Patients Medical records Medicine Midwives Standards Risk assessment Research National Institute for Health and Care Excellence Maternity services Voluntary organisations Training NHS Commissioning Board Health Education England Health and wellbeing boards Clinical commissioning groups Academic health science networks
Legislation
Health and Social Care Bill 2010-12
Link
View this Proceeding contribution on www.publications.parliament.uk